Skip to main content
. Author manuscript; available in PMC: 2013 Dec 24.
Published in final edited form as: Ann Surg Oncol. 2008 Apr 9;15(7):10.1245/s10434-008-9890-5. doi: 10.1245/s10434-008-9890-5

FIG. 1.

FIG. 1

COX-2, but not COX-1 inhibition, reduced the promotion of lung tumor retention (LTR) by surgery. Data are presented as percentage of baseline (control-vehicle) (mean + SEM). Surgery significantly increased LTR (#), and drugs that inhibit COX-2 (indomethacin, etodolac, and celecoxib), but not COX-1 (SC560), significantly attenuated the effect of surgery (*).